Omeros Corporation (OMER)
US$ 11.6811.66%
Price Chart
Key Statistics
Market Cap
$ 221.27M
P/E Ratio
0.00
Revenue (TTM)
$ -30M
Volume
803.15K
52W High
$ 13.60
52W Low
$ 3.00
Dividend Yield
0.00%
Beta
2.42
Technicals
50-Day MA
7.6338
200-Day MA
6.8115
52 Week High
13.6
52 Week Low
3.0001
About OMER
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. .
Employees
202
Headquarters
Seattle, WA
CEO
Dr. Gregory A. Demopulos M.D.
Latest News
The Jewish Studio Process: Omer Edition - JewishBoston
17 hours ago • Google News
Rally and Street Fair to Mark Lag B’Omer in Crown Heights - COLlive
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg